Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H5 VLP Influenza Vaccine Dose-Ranging Study
NCT01244867Phase 2Completed
- Sponsor
- Medicago Inc.
- Start
- Nov 2010
- Primary completion
- Jul 2011
- Modality
- Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of H5 VLP influenza vaccine in Influenza A H5N1 infection (H5N1), sponsored by Medicago Inc.. Started Nov 2010; status: completed.
02
Drugs
H5 VLP influenza vaccine
03
Conditions
Influenza A H5N1 infection (H5N1)
Beyond the preview
Go deeper on NCT01244867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01244867.